Highlights
Image
©Getty Images/Halfpoint Images
- Drug use during pregnancy can affect the health of a pregnant person and their child. For example, a pregnant person’s use or misuse of opioids can cause a newborn infant to experience withdrawal symptoms, a condition known as neonatal opioid withdrawal syndrome. Overdose deaths are also rising among women during and after pregnancy.
- Treatment for a substance use disorder during pregnancy such as behavioral interventions and medication for opioid use disorder reduces health risks, including preterm delivery and low birth weight. Treatment also helps people with substance use disorders stay employed, take care of their children, and engage with their families and communities. However, pregnant people with substance use disorders often face challenges when seeking treatment, including fear, stigma and access to care.
- NIDA plays a leading role in the HEALthy Brain and Child Development (HBCD) Study, which seeks to better understand how drug use during pregnancy interacts with genetics and other biological influences to affect a child’s mental and physical health over time.
Latest from NIDA
More than 321,000 U.S. children lost a parent to drug overdose from 2011 to 2021
Overdose deaths increased in pregnant and postpartum women from early 2018 to late 2021
Innovative projects answer NIDA’s challenge to implement substance use prevention in primary care
Find More Information about Pregnancy, Early Childhood and Substance Use
- Learn more about medications during pregnancy at the Centers for Disease Control and Prevention website.
- Read about alcohol use during pregnancy from the National Institute on Alcohol Abuse and Alcoholism.
- Read about the NIH’s Helping to End Addiction Long-term (HEAL) Initiative.
- For information on exposure to drugs and chemicals while breastfeeding, see the National Library of Medicine’s Drugs and Lactation Database (LactMed).